Wednesday 28 March 2018 Speaker: Phil Allport (University of Birmingham) Title: "From High-Luminosity Large Hadron Collider to Hadron Therapy” Abstract: Silicon detectors developed with a UK company for use at the HL-LHC have been successfully employed to develop a system demonstrating proton Computed Tomography (pCT) as part of the Proton Radiotherapy Verification and Dosimetry Applications (PRaVDA) consortium. The seminar will start with a brief introduction to the HL-LHC with a an overview of the tracker upgrade project before discussing how detectors motivated by the radiation-hardness requirements for that programme have been adapted for use at hadron therapy facilities, both for beam monitoring and for imaging using protons. The motivation for pCT in terms of reduced treatment uncertainties and the results from studies at the iThemba Labs proton therapy facility in South Africa will be presented. Possible future plans are discussed in support of the new NHS proton therapy capabilities being established at the Christie Hospital (Manchester) and UCL Hospital (London), including developments in the context of the STFC Global Challenge Network+ in Advanced Radiotherapy as well as work with the NPL Radiation Dosimetry Group.